Add BrightSurf on Google Email

Johns Hopkins Medicine


How bacteria may promote breast cancer

Pathogenic bacteria in gut and breast tissue can promote breast cancer development by increasing SMOX activity, leading to DNA damage and tumor growth. Targeting SMOX with inhibitors could be a viable strategy to counteract the cancer-promoting effects of microbial dysbiosis.

SourceJohns Hopkins Medicine·JournalCancer Research·DateFeb 16, 2026

Detecting early-stage cancers with a new blood test measuring epigenetic instability

Researchers at Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring DNA methylation patterns. The Epigenetic Instability Index (EII) successfully distinguished patients with early-stage lung and breast cancers from healthy individuals, showing promise in detecting...

SourceJohns Hopkins Medicine·JournalClinical Cancer Research·DateFeb 2, 2026

A new Johns Hopkins Medicine study suggests that certain sex hormones could play an important role in understanding long-term heart health — especially for men living with type 2 diabetes

Researchers found that higher testosterone levels reduced risk, while increased estradiol levels increased cardiovascular risk in male participants. In contrast, women with diabetes showed no significant link between hormone levels and cardiovascular outcomes.

SourceJohns Hopkins Medicine·JournalDiabetes Care·DateJan 26, 2026

Johns Hopkins Children’s Center study tracks declines in annual checkups as teens become young adults

A new study by Johns Hopkins Children's Center researchers found that as teens transition to young adults, they often skip yearly wellness visits with pediatricians or primary care providers. The study suggests that parents, pediatricians, and other primary care providers should encourage annual wellness visits to advance efforts in pr...

SourceJohns Hopkins Medicine·JournalJournal of Adolescent Health·DateJan 9, 2026

Experiments advance potential of protein that makes hydrogen sulfide as a therapeutic target for Alzheimer’s disease

Researchers have identified a key protein that produces hydrogen sulfide gas as a therapeutic target for Alzheimer's disease. Experiments in genetically engineered mice show that this protein, Cystathionine γ-lyase (CSE), plays a critical role in cognitive function and memory formation.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateDec 30, 2025

Cell-free DNA Could Detect Adverse Events from Immunotherapy

Researchers developed a non-invasive blood test to detect genetic material shed by tumors, which can identify adverse events related to immune checkpoint inhibitor therapy. The test found evidence of multi-organ injury in patients with immune-related adverse events, suggesting that the clinical syndromes may represent only a small frac...

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateDec 10, 2025

Protein plays unexpected dual role in protecting brain from oxidative stress damage

A new study from Johns Hopkins Medicine reveals that biliverdin reductase A plays a direct protective role against oxidative stress in neurons, independent of its role producing bilirubin. The enzyme modulates another key protein, NRF2, which regulates the levels of protective proteins and antioxidants in cells.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateNov 3, 2025

Johns Hopkins-led study finds drugs approved for treating pain also reduce bone cancer growth

A Johns Hopkins-led study has found that two analgesic drugs, bupivacaine and rimegepant, can slow the growth of osteosarcoma tumors by inhibiting nerve signaling. The researchers tested these medications in mice with osteosarcoma-like tumors and observed a significant reduction in tumor growth and spread.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateOct 28, 2025

Ending federally funded Ryan White HIV/AIDS program would increase new HIV infections 49% nationwide by 2030, computer model predicts

A Johns Hopkins Medicine-led study predicts that ending federal funding for the Ryan White Program could lead to a 49% increase in new HIV infections across US cities by 2030. The program provides comprehensive medical care and treatment services for approximately 500,000 people annually.

SourceJohns Hopkins Medicine·JournalAnnals of Internal Medicine·DateSep 9, 2025

First-ever clinical trial demonstrates safety, molecular readout and promise of pre- and post-surgery immunotherapy combination for patients with operable mesothelioma

A new study demonstrates the safety and potential benefits of a perioperative combination immune checkpoint blockade in resectable mesothelioma. Patients treated with the regimen lived a median of 28.6 months, with nearly 36% alive and recurrence-free at follow-up.

SourceJohns Hopkins Medicine·JournalNature Medicine·DateSep 8, 2025

Researchers reveal potential molecular link between air pollutants and increased risk of Lewy body dementia

Researchers at Johns Hopkins Medicine reveal a potential molecular link between air pollutants and an increased risk of developing Lewy body dementia. Exposure to fine particulate air pollution (PM2.5) triggered the formation of abnormal alpha-synuclein clumps in mice, similar to those found in human patients with Lewy body dementia.

SourceJohns Hopkins Medicine·JournalScience·DateSep 4, 2025